Seroprevalence Studies in the Albanian Population: Following the March Toward Herd Immunity (2020-2023)
Albanian Journal of Natural and Technical Sciences · 30.12.2024 · 29 (2) · 21-38
DOI: 10.67537/ajnts2902013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Albanian Journal of Natural and Technical Sciences, online erschienen am 30.12.2024. Verfasst von Genc Sulcebe und 5 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The COVID-19 pandemic posed significant public health challenges, particularly in understanding SARS-CoV-2 transmission dynamics and the development of population-level immunity. The present study presents a comprehensive report on the seroprevalence of IgG anti-SARS-CoV-2 antibodies in the Albanian population from 2020 to 2023, offering insights into immunity progression and the impact of vaccination. The study involved five rounds of cross-sectional serosurveys conducted in adults aged 18 to 70 years in Tirana, Albania, during key pandemic periods: June 2020, December 2020, August 2021, August 2022, and April 2023. Participants were randomly selected from five primary health centres, with sample sizes ranging from 164 to 2,025 across rounds. Serological testing was performed using enzyme-linked immunosorbent assays (ELISA) to detect IgG antibodies against SARS-CoV-2 spike (S1) and nucleoprotein (N) antigens. Seropositivity rates and antibody levels were evaluated, and vaccination data were collected through standardized questionnaires. The seroprevalence of anti-S1 antibodies increased from 7.5% in June 2020 to 48.2% in December 2020, reflecting the rapid spread of COVID-19. By August 2021, seroprevalence had risen to 71.7%; by August 2022, it reached 93.1%. The study also identified a significant rise in hybrid immunity, with the proportion of vaccinated individuals who had also been infected increasing from 19.9% in August 2021 to 56.0% in August 2022. In 2022, anti-S1 antibody levels were 2.4 times higher than in 2021, indicating that both vaccination and natural infection contributed to population-level immunity. The findings suggest that the Albanian population may have reached herd immunity by late 2022, primarily due to widespread hybrid immunity. Nonetheless, ongoing vaccination efforts—particularly among high-risk groups such as the elderly and immunocompromised—remain essential. This study provides a foundation for long-term monitoring of SARS-CoV-2 seroprevalence in Albania and offers valuable insights for future vaccination strategies in similar settings.
Zitieren
APA
Sulcebe, G., Shyti, E., Kurti-Prifti, M., Seferi-Qendro, I., Ylli, A., & Perry, M. J. (2024). Seroprevalence Studies in the Albanian Population: Following the March Toward Herd Immunity (2020-2023). Albanian Journal of Natural and Technical Sciences, 29(2), 21-38. https://doi.org/10.67537/ajnts2902013
Vancouver
Sulcebe G, Shyti E, Kurti-Prifti M, Seferi-Qendro I, Ylli A, Perry MJ. Seroprevalence Studies in the Albanian Population: Following the March Toward Herd Immunity (2020-2023). Albanian Journal of Natural and Technical Sciences. 2024;29(2):21-38. doi:10.67537/ajnts2902013
BibTeX
@article{Sulcebe2024,
author = {Sulcebe, Genc and Shyti, Erkena and Kurti-Prifti, Margarita and Seferi-Qendro, Irena and Ylli, Alban and Perry, Melissa J.},
title = {Seroprevalence Studies in the Albanian Population: Following the March Toward Herd Immunity (2020-2023)},
journal = {Albanian Journal of Natural and Technical Sciences},
year = {2024},
volume = {29},
number = {2},
pages = {21--38},
doi = {10.67537/ajnts2902013}
}
EUVIMED